185 related articles for article (PubMed ID: 19087624)
1. [Expression of integrin-beta1 in oral leukoplakia and early invasive carcinoma and its relationship with cell proliferation].
Shang JW; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Oct; 43(10):608-11. PubMed ID: 19087624
[TBL] [Abstract][Full Text] [Related]
2. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of perlecan receptors, α-dystroglycan and integrin β1, before and after invasion of oral squamous cell carcinoma.
Ahsan MS; Yamazaki M; Maruyama S; Kobayashi T; Ida-Yonemochi H; Hasegawa M; Henry Ademola A; Cheng J; Saku T
J Oral Pathol Med; 2011 Aug; 40(7):552-9. PubMed ID: 21198869
[TBL] [Abstract][Full Text] [Related]
4. Expression of alpha(v)beta6 integrin in oral leukoplakia.
Hamidi S; Salo T; Kainulainen T; Epstein J; Lerner K; Larjava H
Br J Cancer; 2000 Apr; 82(8):1433-40. PubMed ID: 10780523
[TBL] [Abstract][Full Text] [Related]
5. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
7. Expression of β1integrin in normal epithelium, oral submucous fibrosis and oral squamous cell carcinoma.
Veeravarmal V; Austin RD; Nagini S; Nassar MHM
Pathol Res Pract; 2018 Feb; 214(2):273-280. PubMed ID: 29113685
[TBL] [Abstract][Full Text] [Related]
8. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma.
Häkkinen L; Kainulainen T; Salo T; Grenman R; Larjava H
Oral Dis; 1999 Jul; 5(3):210-7. PubMed ID: 10483066
[TBL] [Abstract][Full Text] [Related]
9. [Keratin 8 expression in mouth mucosa hyperkeratosis and squamous cell carcinoma ].
Babichenko II; Grigor'ian AS; Katushkina AA
Arkh Patol; 2011; 73(6):18-21. PubMed ID: 22379894
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
11. [Papillomavirus in the genesis of oral leukoplakia].
Babichenko II; Rabinovich OF; Ivina AA; Rabinovich IM; Togonidze AA
Arkh Patol; 2014; 76(1):32-6. PubMed ID: 24745190
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
13. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
[TBL] [Abstract][Full Text] [Related]
14. [Ki-67 and claudin-1 expression in hyperplasia, oral squamous inthraepithelial neoplasia and oral squamous cell carcinoma].
Ivina AA; Babichenko II; Rabinovich OF; Togonidze AA
Stomatologiia (Mosk); 2014; 93(1):31-3. PubMed ID: 24576965
[TBL] [Abstract][Full Text] [Related]
15. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia.
Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Martinez-Lara I
Head Neck; 2000 Oct; 22(7):658-61. PubMed ID: 11002319
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia.
Ishida K; Ito S; Wada N; Deguchi H; Hata T; Hosoda M; Nohno T
Mol Cancer; 2007 Oct; 6():62. PubMed ID: 17922924
[TBL] [Abstract][Full Text] [Related]
18. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
Vered M; Allon I; Dayan D
J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
[TBL] [Abstract][Full Text] [Related]
19. Keratin 10-positive orthokeratotic dysplasia: a new leucoplakia-type precancerous entity of the oral mucosa.
Kobayashi T; Maruyama S; Abé T; Cheng J; Takagi R; Saito C; Saku T
Histopathology; 2012 Nov; 61(5):910-20. PubMed ID: 22734720
[TBL] [Abstract][Full Text] [Related]
20. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
